Monday, 30 July 2018

Sienna Biopharmaceuticals' acne drug fails two trials

Sienna Biopharmaceuticals Inc said on Monday two pivotal trials testing its acne treatment did not meet their main goals of reducing inflammatory lesions on patients' skin.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)